Literature DB >> 27863272

Genome-wide analysis of aberrant gene expression and methylation profiles reveals susceptibility genes and underlying mechanism of cervical cancer.

Hongmei Lin1, Yifei Ma2, Yongqing Wei1, Hui Shang1.   

Abstract

BACKGROUND: This study aimed to explore the molecular mechanism of cervical cancer (CC) by integrated bioinformatic analyses of gene expression and methylation profiles.
METHODS: The gene expression and methylation microarrays in CC samples and normal controls were respectively downloaded from the GEO database. After screening the differentially expressed genes (DEGs) with Limma package and the CC-related methylation sites with CpGassoc package in R language, DEGs with CC-related methylation sites were identified from the intersection of the above two groups of results with 50kb upstream and downstream of a gene as the gene region. Then GO enrichment was performed by GenCLIP2.0 software. Sequentially, analysis of metabolic sub-pathways with pathogenic risk was predicted by iSubpathwayMiner package in R language.
RESULTS: A total of 1357 DEGs including 721 up-regulated and 636 down-regulated, as well as 666 CC-related methylation sites were screened out. After being analyzed, 26 DEGs with 35 CC-related methylation sites were identified. EDN3 and EDNRB were significantly involved in a function cluster in GO terms of vein smooth muscle contraction, vascular smooth muscle contraction and phasic smooth muscle contraction. LHX2 and PAX6 were significantly involved in a function cluster in GO terms of telencephalon regionalization and forebrain regionalization. ACOX3, CYP39A1 and DPYS were significantly enriched in 25 sub-pathways of 6 major pathways.
CONCLUSIONS: EDN3 and EDNRB might play important roles in the molecular mechanism of CC, and LHX2, ACOX3, CYP39A1 and DPYS might be susceptibility genes and potential risk markers in CC.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Differentially expressed genes; Functions enrichment; Methylation sites; Risk biomarkers

Mesh:

Substances:

Year:  2016        PMID: 27863272     DOI: 10.1016/j.ejogrb.2016.10.017

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  7 in total

Review 1.  The Progress of Methylation Regulation in Gene Expression of Cervical Cancer.

Authors:  Chunyang Feng; Junxue Dong; Weiqin Chang; Manhua Cui; Tianmin Xu
Journal:  Int J Genomics       Date:  2018-04-16       Impact factor: 2.326

2.  Nine Genes Mediate the Therapeutic Effects of Iodine-131 Radiotherapy in Thyroid Carcinoma Patients.

Authors:  Han Shuwen; Yang Xi; Da Miao; Xu Jiamin; Zhuang Jing; Gao Weili
Journal:  Dis Markers       Date:  2020-06-16       Impact factor: 3.434

Review 3.  Meta-Analysis of Polymorphic Variants Conferring Genetic Risk to Cervical Cancer in Indian Women Supports CYP1A1zzm321990as an Important Associated Locus

Authors:  Debmalya Sengupta; Udayan Guha; Sagnik Mitra; Sampurna Ghosh; Samsiddhi Bhattacharjee; Mainak Sengupta
Journal:  Asian Pac J Cancer Prev       Date:  2018-08-24

4.  Taraxacum officinale extract ameliorates dextran sodium sulphate-induced colitis by regulating fatty acid degradation and microbial dysbiosis.

Authors:  Wei Chen; Huining Fan; Rui Liang; Rui Zhang; Jing Zhang; Jinshui Zhu
Journal:  J Cell Mol Med       Date:  2019-09-29       Impact factor: 5.310

5.  miR‑27a‑3p regulates the inhibitory influence of endothelin 3 on the tumorigenesis of papillary thyroid cancer cells.

Authors:  Hongxin Chen; Binlin Cai; Kun Liu; Qingquan Hua
Journal:  Mol Med Rep       Date:  2021-02-04       Impact factor: 2.952

6.  Identification of Hub Genes as Potential Prognostic Biomarkers in Cervical Cancer Using Comprehensive Bioinformatics Analysis and Validation Studies.

Authors:  Han Xue; Zhaojun Sun; Weiqing Wu; Dong Du; Shuping Liao
Journal:  Cancer Manag Res       Date:  2021-01-08       Impact factor: 3.989

Review 7.  The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer.

Authors:  Rina Masadah; Syahrul Rauf; Muhammad Yogi Pratama; Claudio Tiribelli; Devis Pascut
Journal:  Cancers (Basel)       Date:  2021-03-09       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.